http://rdf.ncbi.nlm.nih.gov/pubchem/patent/ES-2625044-T3

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f73dac012733ce8c3dbda5177dc07f71
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-70535
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-177
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-17
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-735
filingDate 2013-10-29-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2017-07-18-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7bdd798de6c2087465082e07ad142657
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_96c4adda74bd1525a3c6713e3a642f4d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ccf853ec4266400281dddddd74c9b05d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_35c8fd5b47c53ac6c2e94c230dc373f6
publicationDate 2017-07-18-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber ES-2625044-T3
titleOfInvention A pharmaceutical composition for use in the treatment or prevention of an inflammatory disease or an autoimmune disease, or both
abstract Pharmaceutical composition for use in the treatment or prevention of an inflammatory disease or an autoimmune disease, or both, in which the pharmaceutical composition comprises soluble Fcγ receptor (RFcγ) as an active ingredient and in which the pharmaceutical composition is designed to administer a first dose of a therapeutically effective amount of soluble RFcγ, followed by a safety period of several weeks, followed by a subsequent cycle of treatment of at least two more administrations, wherein said therapeutically effective amount is effective to treat or prevent said disease in said patient.
priorityDate 2012-10-30-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5281078
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP49745
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID7066
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID28417
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP42706
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2909
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID56842161
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID410862584
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP42705
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID451508066
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID21832
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP08101
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419555018
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCAAI30323
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2265
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP35396
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426150178
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ03181
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID100192391
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP40226
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419535430
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID103690065
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419551199
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5329098
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID135449332
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID81811
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419590725
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ6IYE9
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID2213
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2955
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID100189608
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID425930438
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6741
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419491703
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP40225
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID14130

Total number of triples: 53.